138 related articles for article (PubMed ID: 21106208)
1. Clinicopathological study of diffuse neurofibrillary tangles with calcification. With special reference to TDP-43 proteinopathy and alpha-synucleinopathy.
Habuchi C; Iritani S; Sekiguchi H; Torii Y; Ishihara R; Arai T; Hasegawa M; Tsuchiya K; Akiyama H; Shibayama H; Ozaki N
J Neurol Sci; 2011 Feb; 301(1-2):77-85. PubMed ID: 21106208
[TBL] [Abstract][Full Text] [Related]
2. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
[TBL] [Abstract][Full Text] [Related]
3. Distribution of neurofibrillary tangles in diffuse neurofibrillary tangles with calcification.
Ukai K; Shibayama H; Ishihara R; Ozaki N
Psychiatry Clin Neurosci; 2009 Oct; 63(5):646-51. PubMed ID: 19570148
[TBL] [Abstract][Full Text] [Related]
4. An autopsy case of diffuse neurofibrillary tangles with calcification: early stage pathologic findings.
Iwasaki Y; Ito M; Mori K; Deguchi A; Nagaoka M; Yoshida M; Hashizume Y
Neuropathology; 2009 Dec; 29(6):697-703. PubMed ID: 19389080
[TBL] [Abstract][Full Text] [Related]
5. Diffuse neurofibrillary tangles with calcification (Kosaka-Shibayama disease) in Japan.
Ukai K; Kosaka K
Psychiatry Clin Neurosci; 2016 Mar; 70(3):131-40. PubMed ID: 26176797
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325
[TBL] [Abstract][Full Text] [Related]
7. Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity.
Haraguchi T; Ishizu H; Takehisa Y; Kawai K; Yokota O; Terada S; Tsuchiya K; Ikeda K; Morita K; Horike T; Kira S; Kuroda S
Neuroreport; 2001 Dec; 12(18):3887-90. PubMed ID: 11742204
[TBL] [Abstract][Full Text] [Related]
8. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
Tanabe Y; Ishizu H; Ishiguro K; Itoh N; Terada S; Haraguchi T; Kawai K; Kuroda S
Neuroreport; 2000 Aug; 11(11):2473-7. PubMed ID: 10943706
[TBL] [Abstract][Full Text] [Related]
9. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
10. Diffuse neurofibrillary tangles with calcification (a form of dementia): X-ray spectrometric evidence of lead accumulation in calcified regions.
Haraguchi T; Ishizu H; Kawai K; Tanabe Y; Uehira K; Takehisa Y; Terada S; Tsuchiya K; Ikeda K; Kuroda S
Neuroreport; 2001 May; 12(6):1257-60. PubMed ID: 11338202
[TBL] [Abstract][Full Text] [Related]
11. Significance and limitation of the pathological classification of TDP-43 proteinopathy.
Arai T
Neuropathology; 2014 Dec; 34(6):578-88. PubMed ID: 25196969
[TBL] [Abstract][Full Text] [Related]
12. [A new dementia group caused by TDP-43 abnormality].
Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
[TBL] [Abstract][Full Text] [Related]
13. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
[TBL] [Abstract][Full Text] [Related]
14. Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease.
Bayram E; Shan G; Cummings JL
J Alzheimers Dis; 2019; 69(4):953-961. PubMed ID: 31127776
[TBL] [Abstract][Full Text] [Related]
15. [Parkinson's disease dementia: correlations between clinical, neuropsychological and neuropathological features].
Kiesmann M; Vogel T; Kaltenbach G; Mohr M
Rev Neurol (Paris); 2010; 166(6-7):653-6. PubMed ID: 20219224
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.
Aoki N; Murray ME; Ogaki K; Fujioka S; Rutherford NJ; Rademakers R; Ross OA; Dickson DW
Acta Neuropathol; 2015 Jan; 129(1):53-64. PubMed ID: 25367383
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans.
Johnson VE; Stewart W; Trojanowski JQ; Smith DH
Acta Neuropathol; 2011 Dec; 122(6):715-26. PubMed ID: 22101322
[TBL] [Abstract][Full Text] [Related]
18. [An autopsy case of "diffuse neurofibrillary tangles with calcification", multiple infarctions and hyaline arteriosclerosis].
Arai T; Kuroki N; Nizato K; Kase K; Iritani S; Ikeda K
No To Shinkei; 1996 Jan; 48(1):69-76. PubMed ID: 8679323
[TBL] [Abstract][Full Text] [Related]
19. Differences in Symptomatic Presentation and Cognitive Performance Among Participants With LATE-NC Compared to FTLD-TDP.
Teylan MA; Mock C; Gauthreaux K; Culhane JE; Jicha G; Chen YC; Chan KCG; Kukull WA; Nelson PT; Katsumata Y
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1024–1032. PubMed ID: 34597386
[TBL] [Abstract][Full Text] [Related]
20. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
